Pascal Pierre

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Michel Delforge, Dominik Selleslag, Yves Béguin et al. · Leukemia Research · 2014 · 66 citations

Hematological Malignancy, Oncology, Least Six +7

Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit

Pascal Pierre, Olivier Denis, Hervé Bazin et al. · European Journal of Immunology · 1992 · 43 citations

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene

Jo‐Anne van der Krogt, Marlies Vanden Bempt, Nicole Mentens et al. · Haematologica · 2017 · 35 citations · Full text

Savene® (dexrazoxane) use in clinical practice

Christel Fontaine, L. Noens, Pascal Pierre et al. · Supportive Care in Cancer · 2012 · 28 citations

Drug Safety, Medicine, Patient Safety +6

The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulum

Marilyn Registre, Jacky G. Goetz, Pascal Pierre et al. · Biochemical and Biophysical Research Communications · 2004 · 24 citations

Gene Product, Protein Function, Protein Expression +7